Transcranial pulsed electromagnetic fields for multiple chemical sensitivity: study protocol for a randomized,...

Area of Science:

• Neurology
• Environmental Health
• Biomedical Engineering

Background:

• Multiple Chemical Sensitivity (MCS) is a chronic, debilitating condition with unknown causes, characterized by multisystem symptoms triggered by chemical exposures.
• Current treatment options for MCS are limited, with no established evidence-based therapies available.
• Abnormal central nervous system sensory processing is a suspected underlying mechanism in MCS.

Purpose of the Study:

• To evaluate the efficacy of pulsed electromagnetic fields (PEMF) as a treatment for Multiple Chemical Sensitivity (MCS).
• To assess the impact of PEMF on daily life, symptom severity, psychological distress, and quality of life in MCS patients.

Main Methods:

• A randomized, double-blind, placebo-controlled trial involving 40 participants with MCS.
• Participants received either transcranial PEMF therapy or a placebo for 30 minutes twice daily over six consecutive weeks.
• Outcomes, including impact on daily life and symptom severity, were measured at baseline, weekly during treatment, post-treatment, and at follow-up appointments.

Main Results:

• The study is designed to measure the primary outcome of MCS's impact on everyday life.
• Secondary outcomes include MCS symptom reduction, decreased psychological distress, and improved quality of life.
• Immunological markers and hyperalgesia responses will also be assessed.

Conclusions:

• This trial aims to determine if PEMF therapy offers a viable treatment for MCS.
• Positive findings could lead to improved healthcare and a better understanding of this disabling condition.
• The study addresses the critical need for effective interventions for MCS patients.